Innocoll Announces Top-line Results from its Phase 2 Clinical Trial Investigating XaraCol for the Management of Post-operative Pain and Receives “Notice of Allowability” for XaraColl U.S. Patent Application
ASHBURN, Va.,Sept. 13, 2011 /PRNewswire/ –Innocoll, Inc. announced top-line results from its phase 2 clinicaltrial investigating XaraColl for the management of post-operativepain and also announced it has received a “Notice of…
September 13th, 2011
Posted in
Drug